Outcome 4 Flashcards
DNA sequencing refers to
the sequencing of nucleotides in a DNA molecule
What is another name for Sanger sequencing
Chain termination
List the components required for Sanger sequencing
Template DNA with a known short sequence that flanks the 3’end. Primer, heat stable DNA Polymerase, dNTPs, ddNTPs
What are the differences between dNTPs and ddNTPS?
ddNTPs lack a 3’ OH group. This means that chain elongation is terminated as soon as a ddNTP is incorporated into the chain. This is because DNA polymerse catlayses the formation of phophodiester bonds between the 5’ phosphate group of one nucleotide and the 3’OH group of the next.
How are ddNTPs modified for Sanger Sequencing
They are modified to be covalently bonded to fluorescent tags. So they can be identified.
Why is only one primer used for Sanger Sequencing
Unlike PCR, Sanger Sequencing does not seek to amplify target DNA. Focusing on one strand, Sanger Sequencing it aims to synthesise a complementary strand of every possible length.
Describe the first step in Sanger Sequencing?
Template dsDNA, a primer, heat stable DNA poymerase, dNTPs and ddNTPs are mixed together. The each of the 4 types of ddNTP are covalently bonded to floursecent dyes and these 4 flourescent dyes emit light at different wavelengths. The ratio concentration of dNTPs in the mixture is much greater than the concentration of ddNTPs.
The mixture is heated to 95C, the H bonds between the bases of dsDNA are broken, it denatures into ssDNA.
Describe the second step in Sanger Sequencing
The mixture is cooled to 45-60C. Primers, which are present in excess, bind via complementary base pairing to their recognition sites on the template ssDNA. These recognition sites are located on the 3’ flank of the template ssDNA.
Describe the third step in Sanger Sequencing
The mixture is heated to 72C. Heat stable DNA polymerase uses the primer as a starting point and begins catalysing the formation of phosphodiester bonds between the free 3’OH group of the primer and the 5’ phosphate group of a dNTP or ddNTP that is complementary to the correspoing base on the template ssDNA. The length of the extension depends on when a ddNTP is incorporated into the chain, at which point nucleotide chain elongation will cease.
Given enough time, reagents, and a suitable ratio of dNTPs to ddNTPs, at least one DNA strand of every possible length will be produced with a
fluorescent ddNTP at the end.
Describe the analysis step of Sanger Sequencing
Each strand is seperated on size using capillary gel electrophoresis. The smallest fragment will reach the capillary end first, a flourescent detecting laser shooting through the gel will excite the flourescent tag on the ddNTP of the fragment and the wavelength of the light emitted by the terminal ddNTP can be measured. The second shortest fragment will then reach the capillary end and the same process will occur. Once all fragments have reached the capillary end, the sequence of the full length of DNA can be determined. The sequence of the detected fluorescence is then converted computationally into an electropherogram.
Why is capillary gel electrophoresis used instead of agarose gel electrophoresis
Capillary gel is 3 times faster, uses less material and acheives better seperation.
What is an electropherogram
A graph showing the intensity of flourensence emmision over time. in Sanger Sequencing it is used to show the nucleotide sequence.
How is Sanger Sequencing used to detect mutations?
Sanger Sequencing is used to detect single nucleotide variants. It relies on comparision between a patients electropherogram and the electropherogram of a DNA sample that does not contain the mutation. Differences in the electropherograms are analysed for phenotypic effect.
What are two uses of Sanger Sequencing
- To determine a nucleotide sequence
2. To detect single nucleotide variant mutations
What are the features of a microarray
It is a biochip containing thousands of highly ordered spots arranged into rows and columns. Each spot contains multiple copies of ssDNA called probe DNA, that could for example represent a gene or a portion of a gene or a previously known mutation. The location and composition of each spot is recorded in a database.
How is a microarray used to determine whether a patient has a mutation for a specific disease?
A DNA sample from the patient and a control DNA sample which does not contain a mutation of the gene of interest are collected and undergo the same process seperately from one another.
The DNA is denatured into ssDNA.
The ssDNA is cut into smaller fragments and subsequentlly labelled with fluourescent dye.
Different label used for patient and control.
Both sets of labelled DNA are mixed and inserted into the chip. The chip is incubated to allow for hybridisation to occur.
Excess DNA is washed off the chip.
DNA hybridisation can be identified by a microarray scanner which measures flouresence.
If patient has no mutation, both control and patient DNA will bind to the sequences on the chip that represent the normal sequence. If flourescence matching the patients DNA label is detected on the spots which contain mutation fragments then they have a mutation.6